Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > RE: GULLIBLE? YEAH, I BIT, I BIT HARD!
View:
Post by ISAloser247 on Mar 01, 2011 10:38am

RE: GULLIBLE? YEAH, I BIT, I BIT HARD!


...and YOU didn't?       THEY HAD ROCHE SIGNED UP!!!!!!  FOR MOTHER*&#%*** TENS OF MILLIOINS!!!!!!

     Dr. Yatscoff and Dr. Foster and ALL THE U of A hangers-ons,  SPUN A FINE TALE!!!!!  I TRULY HOPE

   THAT ALL INVOLVED , WILL SUFFER, AS HAVE THOSE, ON WHOM THEY HAVE TRANSGRESSED!!!!!!

    As for the juvenile, patheic pumping................
Comment by antoninus on Mar 01, 2011 10:57am
dude, bringing a drug to market in canada is extremely difficult, expensive and time consuming. That said, sure, mistakes were made. However, most if not all public companies make mistakes. The key is learning from them. I think this drug has a chance to earn some decent revenues if it makes it to market in any of the targeted conditions. If it makes it in a few of them, the revenues could be ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities